These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9548407)

  • 1. CP-060S interacts with three principal binding sites on the L-type Ca2+ channel.
    Suzuki Y; Tamura K; Adachi Y; Fukazawa M; Kato T
    Eur J Pharmacol; 1998 Jan; 342(2-3):347-51. PubMed ID: 9548407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of CP-060S on veratridine-induced Ca2+ overload in cardiomyocytes and mechanical activities in vascular strips.
    Tamura K; Suzuki Y; Koga T; Akima M; Kato T; Nabata H
    Eur J Pharmacol; 1996 Sep; 312(2):195-202. PubMed ID: 8894596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CP-060S, a novel Ca(2+) channel blocker, on oxidative stress in cultured cardiac myocytes.
    Hara A; Suzuki T; Hashizume H; Shishido N; Nakamura M; Ushikubi F; Abiko Y
    Eur J Pharmacol; 1999 Nov; 385(1):81-8. PubMed ID: 10594347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric interaction of semotiadil fumarate, a novel benzothiazine, with 1,4-dihydropyridines, phenylalkylamines, and 1,5-benzothiazepines at the Ca(2+)-channel antagonist binding sites in canine skeletal muscle membranes.
    Nakayama K; Nozawa Y; Fukuta Y
    J Cardiovasc Pharmacol; 1994 May; 23(5):731-40. PubMed ID: 7521455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CP-060S on membrane channels in vascular smooth muscle cells from guinea pig.
    Ohya Y; Adachi N; Setoguchi M; Abe I; Fujishima M
    Eur J Pharmacol; 1997 Jul; 330(1):93-9. PubMed ID: 9228418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-ischemic effects of CP-060S during pacing-induced ischemia in anesthetized dogs.
    Adachi Y; Suzuki Y; Homma N; Fukazawa M; Tamura K; Nishie I; Kuromaru O
    Eur J Pharmacol; 1999 Feb; 367(2-3):267-73. PubMed ID: 10079001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of vasoinhibitory effect of cardioprotective agent, CP-060S, in rat aorta.
    Sato K; Satake N; Shibata S; Adachi Y; Karaki H
    Eur J Pharmacol; 2000 Jul; 400(2-3):225-30. PubMed ID: 10988338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effects of CP-060S on ischaemia- and reperfusion- induced arrhythmias in anaesthetized rats.
    Koga T; Fukazawa M; Suzuki Y; Akima M; Adachi Y; Tamura K; Kato T; Kuromaru O
    Br J Pharmacol; 1998 Apr; 123(7):1409-17. PubMed ID: 9579737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.
    Chatelain P; Dewinkeleer P; Beaufort P; Meysmans L; Clinet M
    Eur J Pharmacol; 1994 Apr; 267(2):151-60. PubMed ID: 8050476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CP-060S, a novel cardioprotective drug, in the methacholine-induced ECG change model in rats.
    Fukazawa M; Adachi Y; Akima M; Imagawa JI; Suzuki Y; Kuromaru O; Tamura K
    Fundam Clin Pharmacol; 2001 Apr; 15(2):135-42. PubMed ID: 11468023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CP-060S, a novel cardioprotective drug, limits myocardial infarct size in anesthetized dogs.
    Suzuki Y; Tamura K; Akima M; Adachi Y; Fukazawa M; Kato T
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):400-7. PubMed ID: 9514185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-lasting anti-anginal effects of CP-060S in a rat model of arginine vasopressin-induced myocardial ischaemia.
    Adachi Y; Suzuki Y; Hatanaka T; Fukazawa M; Tamura K
    J Pharm Pharmacol; 2002 Mar; 54(3):413-8. PubMed ID: 11902808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
    Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
    Miwa K; Miyagi Y; Araie E; Sasayama S
    Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue.
    Rutledge A; Triggle DJ
    Eur J Pharmacol; 1995 Jul; 280(2):155-8. PubMed ID: 7589180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W; Rampe D; Triggle DJ
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
    Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CP-060S, a novel cardioprotective drug, on cardiac function and myocardial oxygen consumption.
    Suzuki Y; Akima M; Tamura K
    Gen Pharmacol; 1999 Jan; 32(1):57-63. PubMed ID: 9888255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.